Careers  |  Sign In  |  Register

Latest in Women’s Health

A recent study done by Brigham and Women’s Hospital has found that, contrary to a 2006 FDA report, antidepressants known as serotonin reuptake inhibitors (SSRI’s) do not seem to increase the risk of babies being born with pulmonary hypertension. According to CBS News, the Harvard study looked at 3.8...
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related matters.
An experimental women’s libido drug, flibanserin, developed by Sprout Pharmaceuticals, has been advised for rejection by the FDA advisory panel, according to Reuters. Flibanserin is a selective serotonin reuptake inhibitor (SSRI) and was initially tested as an antidepressant. After it was found to be an...